Patent details

300901 Product Name: pibrentasvir of een farmaceutisch aanvaardbaar zout daarvan

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300901
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2692346
Status:
SPC granted but not yet in force
Application number:
300901
Procedural language:
Dutch
First Applicant Residence Country:
Bahamas (BS)

Paediatric Extension

SPC Extension Filing Date:
03/11/2021
SPC Extension Agent/Owner Name:
AbbVie Bahamas Ltd. , ir. H.A. Witmans c.s.
SPC Extension Status:
Extension Granted
SPC Extension Grant Date:
15/11/2021
SPC Extension Request Refusal Date:
SPC Extension Revocation Date:

Marketing Authorization

Marketing Authorization Number:
EU/1/17/1213
Marketing Authorization Type:
EEA
Marketing Authorization Date:
28/07/2017
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
27/10/2017
First Marketing Authorization date:
28/07/2017
Grant date:
16/11/2017
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
30/10/2017
SPC/SPC Extension Expiration Date:
27/01/2033
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
27/12/2024
 
 

 

Name:
AbbVie Manufacturing Management Unlimited Company
Address:
70 Sir John Rogerson's Quay, Dublin 2, Ireland (IE)

Historical Applicant/holder

From:
27/12/2024
To:
27/12/2024

 

Name:
AbbVie Ireland Unlimited Company
Address:
70 Sir John Rogerson's Quay, Dublin 2, Ireland (IE)

From:
27/10/2017
To:
27/12/2024

 

Name:
AbbVie Bahamas Ltd.
Address:
Sassoon House Shirley Street & Victoria Avenue, New Providence, Nassau, Bahamas (BS)

Agent

1

Name:
ir. B.Ch. Ledeboer c.s
From:
28/07/2025
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

2

Name:
ir. H.A. Witmans c.s.
From:
27/10/2017
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
28/07/2025

Publication

Bulletin

1

Bulletin Heading:
CO
Journal edition number:
02/25
Publication date:
08/01/2025
Description:
Changes in the Netherlands Patent Register

2

Bulletin Heading:
CO
Journal edition number:
02/25
Publication date:
08/01/2025
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
SPC
Journal edition number:
46/21
Publication date:
17/11/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

4

Bulletin Heading:
SPC
Journal edition number:
46/21
Publication date:
17/11/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

5

Bulletin Heading:
SPC
Journal edition number:
47/17
Publication date:
22/11/2017
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

6

Bulletin Heading:
SPC
Journal edition number:
44/17
Publication date:
01/11/2017
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202402351A
Date Registered:
27/12/2024
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. H.A. Witmans c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
AbbVie Ireland Unlimited Company
Address:
70 Sir John Rogerson's Quay, Dublin 2, Ireland (IE)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202402351C
Date Registered:
27/12/2024
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. H.A. Witmans c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
AbbVie Manufacturing Management Unlimited Company
Address:
70 Sir John Rogerson's Quay, Dublin 2, Ireland (IE)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
31/10/2031
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
15/11/2021 Outgoing Correspondence Decision extension duration 1 PDF /2/3/6/8/0/0800208632/docs/300901_1_446099l504c.pdf
15/11/2021 Outgoing Correspondence Confirmation receipt request for extension 1 PDF /2/3/6/8/0/0800208632/docs/300901_9_445965l505.pdf
15/11/2021 Certificate Certificate 1 PDF /2/3/6/8/0/0800208632/docs/300901_15_spcxcertificate20211115125830327.pdf
03/11/2021 SPC Documents Annex SPC 4 PDF /2/3/6/8/0/0800208632/docs/300901_0_supplprotectioncertificate20211115125328997.pdf
03/11/2021 SPC Documents Summary of the characteristics of the product 51 PDF /2/3/6/8/0/0800208632/docs/300901_5_supplprotectioncertificate20211104123636385.pdf
03/11/2021 SPC Documents Marketing Authorization SPC 3 PDF /2/3/6/8/0/0800208632/docs/300901_8_supplprotectioncertificate20211104123636368.pdf
03/11/2021 SPC Documents Annex SPC 3 PDF /2/3/6/8/0/0800208632/docs/300901_10_supplprotectioncertificate20211104123636415.pdf
03/11/2021 Application Form First filed application form 3 PDF /2/3/6/8/0/0800208632/docs/300901_14_applicationform20211104123636256.pdf
03/11/2021 SPC Documents Annex SPC 1 PDF /2/3/6/8/0/0800208632/docs/300901_16_supplprotectioncertificate20211104123636351.pdf
03/11/2021 SPC Documents Annex SPC 26 PDF /2/3/6/8/0/0800208632/docs/300901_17_supplprotectioncertificate20211104123636441.pdf
03/11/2021 SPC Documents Annex SPC 1 PDF /2/3/6/8/0/0800208632/docs/300901_18_supplprotectioncertificate20211115125328965.pdf
16/11/2017 SPC Documents Certificate SPC 1 PDF /2/3/6/8/0/0800208632/docs/300901_11_supplprotectioncertificate20210113020228585.pdf
16/11/2017 Outgoing Correspondence Decision grant 1 PDF /2/3/6/8/0/0800208632/docs/300901_12_outgoingcorrespondence20210113020228514.pdf
30/10/2017 Outgoing Correspondence Confirmation receipt request 1 PDF /2/3/6/8/0/0800208632/docs/300901_2_171378l174.pdf
27/10/2017 SPC Documents Annex SPC 14 PDF /2/3/6/8/0/0800208632/docs/300901_3_supplprotectioncertificate20171030034330156.pdf
27/10/2017 SPC Documents Summary of the characteristics of the product 22 PDF /2/3/6/8/0/0800208632/docs/300901_4_supplprotectioncertificate20171030034329950.pdf
27/10/2017 Application Form First filed application form 3 PDF /2/3/6/8/0/0800208632/docs/300901_6_applicationform20171030034329689.pdf
27/10/2017 SPC Documents Marketing Authorization SPC 3 PDF /2/3/6/8/0/0800208632/docs/300901_7_supplprotectioncertificate20171030034329865.pdf
27/10/2017 SPC Documents Annex SPC 4 PDF /2/3/6/8/0/0800208632/docs/300901_13_supplprotectioncertificate20210113015719543.pdf
27/10/2017 SPC Documents Annex SPC 3 PDF /2/3/6/8/0/0800208632/docs/300901_19_supplprotectioncertificate20171030034330047.pdf